ClinicalTrials.Veeva

Menu
C

Centre for Human Drug Research | Leiden, Netherlands

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ACT-541468
DNL151
Erythromycin
Clindamycin
Pregabalin
POLB 001
JNJ-42847922
EP262
EDP1815
Lu AG06474

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 58 total trials

A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults

2-DG-02 is a randomized, placebo-controlled, double-blind Phase 2 study to investigate the efficacy and safety of 2-Deoxy-D-Glucose as a pre-exposure...

Enrolling
Acute Nasopharyngitis
Other: Placebo
Drug: 2-Deoxy-D-glucose

The goal of this clinical trial is to learn about the safety and the pharmacodynamic (PD) effects of TPM502 in adults with celiac disease. The main q...

Enrolling
Celiac Disease
Drug: TPM502
Other: Placebo

In this study, researchers will learn about a study drug called BIIB115 in healthy male volunteers and in participants with spinal muscular atrophy (...

Enrolling
Muscular Atrophy, Spinal
Healthy Volunteer
Drug: BIIB115-Matching Placebo
Drug: BIIB115

The combined bacteriostatic and immunomodulatory effects of erythromycin and clindamycin will be explored. Treatment effects will be extensively char...

Enrolling
Acne Vulgaris
Drug: 70% topical ethanol solution
Drug: Clindamycin 1% topical lotion formulation

This study will investigate the safety and tolerability of multiple intravenous infusions of NX210c with two ascending doses as well as NX210c pharma...

Enrolling
Healthy Elderly
Drug: Placebo
Drug: NX210c

A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Explora...

Enrolling
Muscular Dystrophy, Landouzy Dejerine
Fascioscapulohumeral Muscular Dystrophy
Drug: AOC 1020
Drug: Placebo

This phase 1b trial will evaluate the effects of EP262 in subjects with Chronic Inducible Urticaria (CIndU), including symptomatic dermographism and...

Enrolling
Chronic Inducible Urticaria
Drug: Oral EP262

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects with Chronic Spontaneous Urtica...

Enrolling
Chronic Spontaneous Urticaria
Drug: Placebo
Drug: Oral EP262

This study aims to assess the safety and tolerability of single ascending, and fixed repeated doses of N,N-Dimethyltryptamine (DMT) in healthy subjec...

Active, not recruiting
Stroke
Drug: N,N-Dimethyltryptamine
Drug: Placebo

Trial sponsors

C
Idorsia Pharmaceuticals logo
Pfizer logo
Janssen (J&J Innovative Medicine) logo
Biogen logo
E
Maruho logo
Alexza Pharmaceuticals logo
A
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems